The Claim
In rats with cerebral ischemia/reperfusion injury, administration of BPC 157 is associated with increased expression of Nos3 and Nos1 and decreased expression of Nos2, indicating a shift in nitric oxide synthase activity toward protective rather than damaging nitric oxide signaling.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In rats suffering brain injury from interrupted and restored blood flow, BPC 157 treatment is linked to higher levels of two nitric oxide-producing enzymes associated with protection and lower levels of one associated with damage.
See the scientific wording
In rats with cerebral ischemia/reperfusion injury, BPC 157 administration is associated with increased expression of Nos3 and Nos1 and decreased expression of Nos2, suggesting a shift in nitric oxide synthase activity toward protective rather than damaging nitric oxide signaling.
A specific peptide triggers a signal in blood vessel and brain cells that turns on survival pathways, which increases enzymes that make beneficial nitric oxide and turns off the enzyme that makes harmful nitric oxide, reducing brain cell damage after a stroke-like injury.
What the research says
1 studyStudy: The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats
In rats with a brain injury similar to a stroke, a special peptide called BPC 157 helped fix brain damage by turning up helpful enzymes and turning down harmful ones that make nitric oxide. This made the rats recover better.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.